Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Cousins Properties	CUZ	31. jan 2025	30.53	+0.76
Covenant Logistics Group	CVLG	31. jan 2025	27.71	-2.08
Coya Therapeutics	COYA	31. jan 2025	6.08	+3.75
CPS Technologies	CPSH	31. jan 2025	1.75	-2.53
CRA International	CRAI	31. jan 2025	183.58	-1.98
Cracker Barrel Old Country Store	CBRL	31. jan 2025	64.98	+0.42
Crane Company	CR	31. jan 2025	170.32	-0.77
Crane NXT	CXT	31. jan 2025	63.97	-0.40
Crawford & Company A	CRD-A	31. jan 2025	12.01	-0.99
Crawford & Company B	CRD-B	31. jan 2025	11.75	-2.08
Creative Global Technology	CGTL	31. jan 2025	5.24	0.00
Creative Media & Community Trust	CMCT	31. jan 2025	0.76	+13.18
Creative Medical Technology	CELZ	31. jan 2025	3.13	-7.40
Creative Realities	CREX	31. jan 2025	2.50	+0.60
Credicorp	BAP	31. jan 2025	183.10	-1.12
Credit Acceptance	CACC	31. jan 2025	507.77	-1.22
Credit Enhanced Corts Trust Aon Capital A	KTN	31. jan 2025	26.77	+1.13
Credit Suisse Ag	SLVO	31. jan 2025	78.00	-0.06
Credit Suisse Ag	GLDI	31. jan 2025	158.00	+0.01
Credit Suisse Asset Management Income Fund	CIK	31. jan 2025	2.99	+1.01
Credit Suisse Gold Shares Covered Calls ETN	USOI	31. jan 2025	64.88	+0.15
Credit Suisse High Yield Bond Fund	DHY	31. jan 2025	2.14	+1.42
Credo Technology	CRDO	31. jan 2025	70.02	+8.39
Crescent Capital BDC	CCAP	31. jan 2025	19.60	+0.36
Crescent Energy	CRGY	31. jan 2025	15.06	-2.52
Cresud A ADR	CRESY	31. jan 2025	12.84	-2.65
Crexendo	CXDO	31. jan 2025	5.77	+0.17
CRH	CRH	31. jan 2025	99.03	-0.76
Cricut A	CRCT	31. jan 2025	5.37	-2.01
Crinetics Pharmaceuticals	CRNX	31. jan 2025	40.30	+0.10

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.